ALCIDION GROUP LIMITED — Board/Management Information 2021

Nov 16, 2021

==> picture [132 x 35] intentionally omitted <==

17 November 2021

Australian Securities Exchange 20 Bridge Street Sydney NSW 2000

Non-Executive Director Resignation

Melbourne, Australia – Alcidion Group Limited (ASX:ALC) advises that Mr Nicholas Dignam has stepped down as a Non-Executive Director, effective 17 November 2021 as noted at the Company’s 2021 Annual General Meeting.

The Board thanks Mr Dignam for his valued contribution to the Company since 2016.

Alcidion Chair Rebecca Wilson said, “Nick has made a significant contribution to the Alcidion Board at a time of rapid growth. His capital markets’ experience has been particularly valuable in contributing to our acquisition program which has included MKM, Patientrack, SmartPage, and ExtraMed.”

An Appendix 3Z in relation to Mr Dignam’s resignation will be lodged in conjunction with this announcement.

This announcement is authorised for release by the Board of Directors of Alcidion Group Limited.

ENDS

For further information, please contact:

Hannah Howlett

WE Communications Ph: +61 4 5064 8064 hhowlett@we-worldwide.com

About Alcidion Group Limited (ASX:ALC)

Alcidion Group Limited (Alcidion) has a simple purpose: to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia and New Zealand to now service over 300 hospitals and 60 healthcare organisations, with further geographical expansion planned.

Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 |+61 3 8060 6177 | www.alcidion.com

==> picture [88 x 24] intentionally omitted <==

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

www.alcidion.com

Page 2 of 2

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity ALCIDION GROUP LIMITED ABN 77 143 142 410

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

the director for the purposes of section 205G of the	Corporations Act.
Name of director	Nicholas Paul Dignam
Date of last notice	22 February 2016
Date that director ceased to be director	17 November 2021

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

• See chapter 19 for defined terms.

Appendix 3Z Page 1

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of Number & class of securities interest Note: Provide details of the circumstances giving rise to the relevant interest Nil

Part 3 – Director’s interests in contracts

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
No. and class of securities to which interest relates	N/A

• See chapter 19 for defined terms.

Appendix 3Z Page 2